HTLV-I Infection: Clinical Trials

1 trial for HTLV-I Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1

Follow HTLV-I Infection: new trials by email Literature Review of HTLV-I Infection trials Research Report on HTLV-I Infection

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Raltegravir for HAM/TSP
Raltegravir - HTLV-I Infection
Early Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)192013-09-052023-03-30

Narrower conditions

HTLV-I Infections (1)  ·  Paraparesis, Tropical Spastic (1)

Broader conditions

Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Deltaretrovirus Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Myelitis (1)  ·  Nervous System Diseases (1)  ·  Neuroinflammatory Diseases (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Spinal Cord Diseases (1)  ·  Virus Diseases (1)

Interventions

Raltegravir Potassium (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (1)

Countries

United States (1)

Top investigators

Steven Jacobson, Ph.D. (1)

Results publications

PMID 34562313